Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

G

GC Cell

Status

Completed

Conditions

Hepatocellular Carcinoma

Study type

Observational

Funder types

Industry

Identifiers

NCT01890291
IIC-I02

Details and patient eligibility

About

To observation that long term follow-up study of 'Immuncell-LC groups' and 'Non-treatment groups' in patient undergo curative resection (PEIT, RFA or Operation) for hepatocellular carcinoma in Korea

Enrollment

162 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Prior to the test, patient is fully explained about the purpose/ contents and characteristics of the testing medication, and the patient him(her)self, the guardian or the legal representative signed on written consent.
  • Patients of participated in the(ClinicalTrials.gov Identifier:NCT00699816)clinical trial.

Exclusion criteria

Patient who is incongruent to this clinical trial by sub-investigator's opinion.

Trial design

162 participants in 2 patient groups

Non-treatment Group
Description:
Patients who were in non-treatment group in phase 3 clinical trial IIC-I01(NCT00699816).
Immuncell-LC Group
Description:
Patients who were in Immuncell-LC group in phase 3 clinical trial IIC-I01(NCT00699816).

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems